L&C Bio Co. Ltd (290650) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, L&C Bio Co. Ltd (290650) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.79 Billion ≈ $2.57 Million USD) by net assets (₩266.71 Billion ≈ $180.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See L&C Bio Co. Ltd (290650) balance sheet quality index to measure how much of total assets are equity-financed.

L&C Bio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how L&C Bio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is L&C Bio Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

L&C Bio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of L&C Bio Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arctech Solar Holding Co Ltd SHG:688408	0.068x
Rastar Group SHE:300043	0.046x
Yueyang Forest & Paper Co Ltd SHG:600963	-0.032x
RIAMB (Beijing) Tech Dvlp Co SHG:603082	0.021x
JOST Werke AG XETRA:JST	0.081x
SG Fleet Group Ltd AU:SGF	-0.064x
Aerosun Corp SHG:600501	0.128x
Morguard Corporation TO:MRC	0.007x

Annual Cash Flow Conversion Efficiency for L&C Bio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of L&C Bio Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is L&C Bio Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩284.35 Billion ≈ $192.70 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.030x	+63.51%
2023-12-31	₩146.94 Billion ≈ $99.58 Million	₩-12.13 Billion ≈ $-8.22 Million	-0.083x	-33.11%
2022-12-31	₩97.95 Billion ≈ $66.38 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.062x	-148.35%
2021-12-31	₩85.02 Billion ≈ $57.62 Million	₩10.91 Billion ≈ $7.39 Million	0.128x	-0.05%
2020-12-31	₩57.81 Billion ≈ $39.17 Million	₩7.42 Billion ≈ $5.03 Million	0.128x	+16.12%
2019-12-31	₩58.18 Billion ≈ $39.43 Million	₩6.43 Billion ≈ $4.36 Million	0.111x	+50.78%
2018-12-31	₩52.46 Billion ≈ $35.55 Million	₩3.85 Billion ≈ $2.61 Million	0.073x	-67.72%
2017-12-31	₩16.81 Billion ≈ $11.39 Million	₩3.82 Billion ≈ $2.59 Million	0.227x	+1327.62%
2016-12-31	₩10.02 Billion ≈ $6.79 Million	₩-185.35 Million ≈ $-125.61K	-0.018x	+94.55%
2015-12-31	₩3.91 Billion ≈ $2.65 Million	₩-1.33 Billion ≈ $-899.78K	-0.339x	--

About L&C Bio Co. Ltd

KQ:290650 Korea Medical Devices

Market Cap

$865.89 Million

₩1.28 Trillion KRW

Market Cap Rank

#9372 Global

#235 in Korea

Share Price

₩51900.00

Change (1 day)

+0.78%

52-Week Range

₩29400.00 - ₩118300.00

All Time High

₩118300.00